Trond Trætteberg Serkland's picture

Trond Trætteberg Serkland

PhD Candidate
  • E-mailtrond.serkland@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman. Journal of Analytical Toxicology. e44-e47.
  • Show author(s) (2022). Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry and Advances in the Clinical Lab. 53-60.
  • Show author(s) (2021). Oxazepam Detected in Urine 79 Days After Withdrawal of Diazepam: A Case Report. Journal of addiction medicine. e274-e277.
  • Show author(s) (2019). Bør flere tilbys behandling med cannabinoider? Tidsskrift for Den norske legeforening. 1-5.
Academic lecture
  • Show author(s) (2022). Rituximab in the treatment of multiple sclerosis: A pharmacokinetic-pharmacodynamic model.
Reader opinion piece
  • Show author(s) (2019). T.T. Serkland og medarbeidere svarer : . Tidsskrift for Den norske legeforening. 1536.
  • Show author(s) (2018). Akutt telefonisk varsling om avvikende farmakologiske prøvesvar : . Tidsskrift for Den norske legeforening. 1694-1695.
Masters thesis
  • Show author(s) (2020). Drug transport in blood: Lipoproteins as transporters of psychotropic drugs.
  • Show author(s) (2023). "Virtual Pharma" - a digital tool for visualizing pharmacokinetics and pharmacodynamics.
  • Show author(s) (2022). LC-MS/MS quantification of ocrelizumab in the treatment of multiple sclerosis .
  • Show author(s) (2021). Establishing an LC-MS/MS method as a tool in a TDM approach when treating multiple sclerosis with monoclonal antibodies.

More information in national current research information system (CRIStin)